Education
About Us
Working with TipRanks
Follow Us
Perrigo Company (PRGO)
:PRGO
PRGO Stock Chart & Stats
$21.62
-$0.12(-0.48%)
At close: 4:00 PM EST
$21.62
-$0.12(-0.48%)
Day’s Range― - ―
52-Week Range$12.17 - $30.93
Previous CloseN/A
Volume301.70K
Average Volume (3M)1.94M
Market Cap
$2.78B
Enterprise ValueN/A
Total Cash (Recent Filing)$432.10M
Total Debt (Recent Filing)$3.83B
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Feb 26, 2026EPS Estimate
0.81Last Dividend Ex-Date
Nov 28, 2025Dividend Yield8.69%
Share Statistics
EPS (TTM)0.80
Shares Outstanding137,582,810
10 Day Avg. Volume2,294,497
30 Day Avg. Volume1,941,999
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.81
P/FCF Ratio14.44
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$27.50Price Target Upside27.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Divestiture And Investment StrategyPRGO could unlock cash by selling the infant formula business that is seeing sell-outs stabilize and focus on investing elsewhere, and more cash could be unlocked with the Oral Care business.
Market TrendsConsumers are increasingly buying private label products, which aligns with Perrigo's offerings.
Strategic InitiativesManagement is still progressing on its 'Three S' plan (stabilize, streamline, strengthen) including winning unit share in OTC and net contract wins.
Bears Say
Consumer Spending BehaviorAn increased focus on value was echoed across the survey, with consumers indicating they are purchasing PL more, are more focused on price when purchasing products, and are shopping more at value outlets such as mass or dollar stores for personal care.
Infant Formula BusinessThe infant formula business was pressured with the overall nutrition business down -21.5% YOY due to velocities below expectations and lapping a period where infant formula benefited from selling into retailers due to the port strike LY.
Sales DeclineSales were impacted by a -4.4% decline in organic sales, -1.3% decline from divestitures and exited products, and +1.6% benefit from FX.
Perrigo Company News
PRGO FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $12.17 and its highest was $30.93 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is $2.78B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Feb 26, 2026 which is in 88 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on Nov 05, 2025. The company reported $0.8 earnings per share for the quarter, beating the consensus estimate of $0.754 by $0.046.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 8.69%. See more information on Perrigo Company dividends here
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 0.81.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 137,582,810 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of $0.8 in its last earnings report, beating expectations of $0.754. Following the earnings report the stock price went down -25.211%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in PRGO
Perrigo Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.50 (27.20% Upside)
$27.50 (27.20% Upside)
Blogger Sentiment
Bullish
PRGO Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 77.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $355.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 35.0%
Last 30 Days ▲ 35.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.82%
12-Months-Change
Fundamentals
Return on Equity
-0.65%
Trailing 12-Months
Asset Growth
-2.92%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Company plc is a global healthcare supplier focused on providing quality over-the-counter (OTC) consumer products and prescription pharmaceuticals. Headquartered in Dublin, Ireland, Perrigo operates primarily in the Consumer Self-Care and Prescription segments. The company offers a wide range of products, including personal care items, dietary supplements, baby care products, and over-the-counter medications, catering to the needs of consumers and healthcare professionals worldwide.
PRGO Company Deck
PRGO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Perrigo demonstrated strong share gains and operational efficiencies in a challenging market, with notable achievements in U.S. OTC and European brand performance. However, the decline in organic net sales, particularly in the OTC and Infant Formula segments, along with soft market conditions, offset some of these gains. The company remains focused on strategic reviews and cost management to navigate these challenges.View all PRGO earnings summariesPRGO Stock 12 Month Forecast
Average Price Target
$27.50
▲(27.20% Upside)
Technical Analysis
Viatris
―
Supernus Pharmaceuticals
―
Teva Pharmaceutical
―
Indivior
―
Amneal Pharmaceuticals
―
Ownership Overview
0.33% Insiders
32.61% Mutual Funds
32.60% Other Institutional Investors
5.59% Public Companies and
Individual Investors